EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and TLRY
Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Tilray Brands (TLRY). These companies are all part of the "medical" sector.
Spectral Medical vs. Its Competitors
Akumin (TSE:AKU) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.
In the previous week, Spectral Medical had 1 more articles in the media than Akumin. MarketBeat recorded 1 mentions for Spectral Medical and 0 mentions for Akumin. Spectral Medical's average media sentiment score of 0.67 beat Akumin's score of 0.00 indicating that Spectral Medical is being referred to more favorably in the news media.
Spectral Medical has lower revenue, but higher earnings than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks.
Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.
30.3% of Akumin shares are owned by institutional investors. Comparatively, 0.0% of Spectral Medical shares are owned by institutional investors. 33.0% of Akumin shares are owned by insiders. Comparatively, 18.2% of Spectral Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Akumin has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.246437, suggesting that its share price is 75% less volatile than the S&P 500.
Summary
Akumin and Spectral Medical tied by winning 6 of the 12 factors compared between the two stocks.
Get Spectral Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral Medical Competitors List
Related Companies and Tools
This page (TSE:EDT) was last updated on 9/15/2025 by MarketBeat.com Staff
Free EDT Stock Alerts